Virginia Commonwealth University
Clinical trials sponsored by Virginia Commonwealth University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Spinal stimulation and exercise may restore hand function in paralysis Results expected Sep 2026 (estimated)
- Can a tablet and home monitors help you manage diabetes and high blood pressure? Results expected Sep 2026 (estimated)
- New hope for kidney transplant patients: safer CMV prevention on the horizon? Results expected Sep 2026 (estimated)
- Virtual reality takes aim at gun violence in new trial Results expected Sep 2026 (estimated)
- New study aims to sharpen tools for tracking becker muscular dystrophy Results expected Sep 2026 (estimated)
-
Aiming for less medication after kidney transplant: a trial tests a safer path for older adults
Disease control Not yet recruitingThis trial tests whether older adults who had a kidney transplant more than a year ago can safely stop taking mycophenolate mofetil (MMF), a drug that helps prevent rejection but can cause infections, stomach issues, and cancer over time. Researchers will use blood and urine test…
Early phase 1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Earpiece zaps nerves to shrink Radiation-Damaged brain swelling
Disease control Not yet recruitingThis trial tests whether a gentle electrical earpiece, worn twice daily for two weeks, can reduce brain swelling caused by radiation necrosis. The device stimulates a nerve in the ear to calm inflammation. Forty people with brain tumors who need a laser procedure will be randomly…
Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug takes aim at hard-to-treat neuroendocrine prostate cancer
Disease control Not yet recruitingThis phase 2 trial tests a drug called sacituzumab tirumotecan in people with neuroendocrine prostate cancer, a rare and aggressive form that has progressed after platinum-based chemotherapy. The drug is given by IV infusion three times per 42-day cycle. The study measures how ma…
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a single day of radiation replace weeks of treatment for breast cancer?
Disease control Not yet recruitingThe SASHA trial is testing whether a single, high-dose radiation treatment delivered directly to the tumor site over one day is safe and effective for women with early-stage breast cancer. The study will enroll 134 women aged 40-85 who have already had a lumpectomy. Researchers w…
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radiation-Free brain imaging for kids? ultrasound may offer a safer path
Diagnosis Not yet recruitingThis study tests whether a portable, radiation-free ultrasound performed at the bedside can accurately detect brain injuries in children, compared to the standard head CT scan. Researchers will enroll 220 children aged 2-17 who are already scheduled for a head CT due to suspected…
Sponsor: Virginia Commonwealth University • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
New program aims to keep teens safe from gun injuries
Prevention Not yet recruitingThis study aims to improve an existing violence prevention program for high-risk youth by adding content that directly addresses firearm safety. Researchers will work with about 45 teens aged 13-17 to develop and test new materials. The goal is to reduce the risk of intentional f…
Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Neighbors may hold the key to boosting colon cancer screening
Prevention Not yet recruitingThis trial tests a program where trained community members, called Colon Health Champions, lead discussions about colorectal cancer risk and screening barriers. The goal is to see if this peer-led approach is feasible and acceptable for adults aged 45 to 75 who are due for routin…
Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Breathing your way to better heart health: new POTS study
Symptom relief Not yet recruitingThis study tests whether regular breathing exercises can improve symptoms of Postural Tachycardia Syndrome (POTS), a condition that causes dizziness and rapid heartbeat when standing. Twelve adults with POTS will practice breathing exercises daily for four weeks while researchers…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a gentle vibrating wearable reduce Self-Harm in autistic kids?
Symptom relief Not yet recruitingThis study will test whether a wearable device called Apollo Neuro is practical and acceptable for autistic children aged 6 to 14 who hurt themselves. The device delivers low-intensity vibrations through the skin. For about a month, 18 children will wear it at least 3 hours a day…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Sound waves could spot stroke dangers early
Knowledge-focused Not yet recruitingThis study will use transcranial Doppler (TCD) ultrasound to measure blood flow in the brains of 100 people who had a stroke and underwent endovascular therapy (clot removal). The goal is to see if TCD readings can predict complications like bleeding or brain swelling in the days…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Kids vs. cancer: can a text from your child save your life?
Knowledge-focused Not yet recruitingThis study explores whether a younger adult (ages 25-44) can encourage an older family member (ages 45-75) in rural areas to get screened for colorectal cancer. Researchers will first survey 300 people, then run focus groups, and finally test the approach with 15 parent-child pai…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
1,000 gene carriers tracked to unlock amyloidosis secrets
Knowledge-focused Not yet recruitingThis study is a registry that will collect health information from 1,000 people who carry the gene for hereditary amyloidosis, including those with and without symptoms. Researchers will track who develops the disease and how it progresses, including the need for heart transplant…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC